Unlock instant, AI-driven research and patent intelligence for your innovation.

Improved AS1411 nucleic acid aptamer and EVs coupled by using same

A technology of AS1411, 5T-AS1411, applied in the field of tumor biotherapy, can solve the problems of lack of targeting and limited application effect of EVs in extracellular vesicles

Active Publication Date: 2022-04-29
ZHENGZHOU UNIV
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the lack of certain targeting of extracellular vesicle EVs, its practical application effect is relatively limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Improved AS1411 nucleic acid aptamer and EVs coupled by using same
  • Improved AS1411 nucleic acid aptamer and EVs coupled by using same
  • Improved AS1411 nucleic acid aptamer and EVs coupled by using same

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment

[0043] The present application will be further explained below in conjunction with the accompanying drawings and embodiments. Before introducing the specific embodiments, the experimental background of some biological materials, experimental reagents, experimental equipment, etc. involved in the following embodiments is briefly introduced as follows.

[0044] biomaterials:

[0045] 4T1 cells, Shanghai Cell Bank, Chinese Academy of Sciences;

[0046] Balb / C mice (6-week-old, female, SPF grade) were purchased from Beijing Weitong Lihua Co., Ltd., and the feeding conditions were: 23-25°C, relative humidity 55%-60%, and the daily lighting time was maintained at 12 Hours (lights on at 8:00 am and off at 8:00 pm every day);

[0047] Cholesterol - 13 T bases - AS1411:

[0048]cholesterol-TTTTTTTTTTTT-TTGGTGGTGGTGGTTGTGGTGGTGGTGG),

[0049] Cholesterol - 9 T bases - AS1411:

[0050] cholesterol-TTTTTTTT-TTGGTGGTGGTGGTTGTGGTGGTGGTGG,

[0051] Cholesterol-9 T bases-AS1411 random s...

Embodiment 1

[0077] Before further introducing the specific technical solutions of the present application, in this example, the inventor first briefly introduces the extraction method of Escherichia coli outer membrane vesicles (OMVs) (Outer Membrane Vesicles) involved in the present application as follows.

[0078] The preparation of Escherichia coli outer membrane vesicle OMVs was specifically obtained by extraction as follows:

[0079] First, the preserved Enterobacter strains were inoculated on a solid LB plate containing 100 mg / mL ampicillin, and incubated upside down at 37°C for 12 h in a constant temperature incubator;

[0080] Subsequently, single clones were picked and transferred to 5 mL LB liquid medium containing 100 mg / mL ampicillin, cultured with shaking at 220 rpm at 37°C for 12 h; Penicillin 100 mL LB liquid medium, 37 ° C, 220 rpm shaking culture for 12 h;

[0081] Finally, take 50 mL of the bacterial liquid, centrifuge at 100,000 g for 30 min, discard the precipitate, a...

Embodiment 2

[0085] On the basis of the Escherichia coli OMVs prepared in Example 1, the inventors further coupled the cholesterol-modified nucleic acid aptamer AS1411 (the nucleic acid aptamer mainly has the targeting ability) to it, and in order to determine the Whether the base length between cholesterol and AS1411 affects the targeting ability of coupled OMVs, the inventors designed three base length AS1411 targeting systems: 5 T AS1411 (5T-AS1411), 9 T AS1411 (9T-AS141), 13 T AS1411 (13T-AS1411), and designed a 9 T random sequence AS1411 (9T-S-AS1411) as a control (random sequence AS1411 has no targeting ability), That is:

[0086] 5T-AS1411: cholesterol-TTTTT-TTGGTGGTGGTGGTTGTGGTGGTGGTGG,

[0087] 9T-AS141: cholesterol-TTTTTTTTTT-TTGGTGGTGGTGGTTGTGGTGGTGGTGG,

[0088] 9T-S-AS1411:cholesterol-TTTTTTTTTT-ATCGATCGATCGATCGATCGATCGATCGA,

[0089] 13T-AS1411: cholesterol-TTTTTTTTTTTTTT-TTGGTGGTGGTGGTTGTGGTGGTGGTGG),

[0090] When coupling the above-mentioned nucleic acid aptamers with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of tumor biological treatment, and particularly relates to an improved AS1411 nucleic acid aptamer and extracellular vesicles (EVs) coupled with the improved AS1411 nucleic acid aptamer. The improved AS1411 nucleic acid aptamer is characterized in that the structure of the improved AS1411 nucleic acid aptamer is cholesterol-T basic group-AS1411; the number of the T basic groups is 5 to 13. The improved AS1411 nucleic acid aptamer can be further coupled with EVs, and after specific tumor cells are targeted, drugs carried by the EVs are utilized to play an anti-tumor role. According to the present invention, the new 9T-AS1411-OMVs capable of being well coupled with Escherichia coli extracellular vesicles (E. coli OMVs) and having good targeting property are obtained by further modifying and screening the existing nucleic acid aptamer AS1411, such that the good technical foundation can be established for the improvement of the targeting property of the OMVs and the improvement of the treatment application effect of the OMVs.

Description

technical field [0001] This application belongs to the technical field of tumor biotherapy, and specifically relates to a patent application for an improved AS1411 nucleic acid aptamer and its coupled EVs. Background technique [0002] Nucleic acid aptamer is a short single-stranded DNA or RNA sequence that forms a specific three-dimensional structure in the body and then binds to the target protein with high affinity to exert certain physiological functions. Nucleic acid aptamers, also known as chemical antibodies, have the characteristics of strong stability, strong specificity, and strong affinity compared with conventional monoclonal antibodies. AS1411 is the first AS1411 to enter clinical research. It can specifically bind to nucleolin on the surface of cancer cells, and nucleolin is highly expressed on the surface of various cancer cell membranes, so it has a better targeting effect. [0003] Extracellular vesicles (Extracellular Vesicles, EVs) are small spherical ves...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/115C12N1/20A61K47/54A61K47/69A61K31/7105A61P35/00C12R1/19
CPCC12N15/115C12N1/20C12N1/005A61K47/6901A61K47/549A61K31/7105A61P35/00C12N2310/16C12N2310/3515C12N2320/32Y02A50/30
Inventor 翁海波崔晨阳孙召伟杨明妍程家萁王佳佳亢洁年嫄茹马文杰赫倩李金红陈振宽
Owner ZHENGZHOU UNIV